SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-112356
Filing Date
2021-09-02
Accepted
2021-09-02 12:20:03
Documents
13
Period of Report
2021-08-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2126886d1_8k.htm   iXBRL 8-K 28393
  Complete submission text file 0001104659-21-112356.txt   254710

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA huma-20210827.xsd EX-101.SCH 3841
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE huma-20210827_def.xml EX-101.DEF 28407
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE huma-20210827_lab.xml EX-101.LAB 38064
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE huma-20210827_pre.xml EX-101.PRE 27032
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2126886d1_8k_htm.xml XML 5649
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39532 | Film No.: 211232267
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences